Kaishan Tao
0000-0002-8573-0445
Publication & Citation Trends
Publications
0 total
China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition)
Cited by 22
Semantic Scholar
Gold Nanoparticles Carrying Mannose-Binding Lectin and Inflammatory Cytokine Antibodies Improve Sepsis Survival by Modulating Immunity and Reducing Pathogens.
Cited by 6
Semantic Scholar
Assessing the Impact of Multidisciplinary Team (MDT) Care on Patients with Liver Cancer/Cirrhosis: A Systematic Review and Meta-Analysis OA
Cited by 0
Semantic Scholar
Circular RNAs in tumor immunity and immunotherapy OA
Cited by 32
Semantic Scholar
Osteopontin: an indispensable component in common liver, pancreatic, and biliary related disease OA
Cited by 5
Semantic Scholar
Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD.
Cited by 86
Semantic Scholar
Deficiency of ASGR1 promotes liver injury by increasing GP73-mediated hepatic endoplasmic reticulum stress OA
Cited by 38
Semantic Scholar
Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
Cited by 9
Semantic Scholar
Research Topics
Organ Transplantation Techniques and Outcomes
(26)
Liver physiology and pathology
(20)
MicroRNA in disease regulation
(19)
Hepatocellular Carcinoma Treatment and Prognosis
(18)
Cancer-related molecular mechanisms research
(16)
Affiliations
National Natural Science Foundation of China
Second Military Medical University
Shanghai Jiao Tong University
Chinese Academy of Sciences
Peking University